Relationship between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Hyperhomocysteinemia in Patients with Ischemic Stroke: A Proof-of-Concept Randomized Trial

Table 1

The clinical data and laboratory indexes of the HHCY group and the NHCY group were compared ().

Indexes	NHCY(69)	HHCY(41)	t/χ^2	P-value
Gender, male (female)	55 (14)	32 (9)	0.043	0.836
Age, (year)	(47-95)	(43-95)	0.137	0.891
History of diabetes, yes (no)	23 (46)	8 (33)	2.427	0.119
History of hypertension, yes (no)	55 (14)	34 (7)	0.172	0.678
History of smoking, yes (no)	19 (50)	14 (27)	0.535	0.464
History of drinking, yes (no)	18 (51)	12 (29)	0.131	0.717
WBC (10^9·L^-1)	(2.55-8.37)	(3.37-16.39)	3.616	0.001
N (10^9·L^-1)	(1.65-5.64)	(2.5-14.8)	4.457	<0.001
L (10^9·L^-1)	(0.57-2.64)	(0.50-2.72)	-3.256	0.002
NLR	(0.82-3.04)	(1.36-18.63)	4.464	<0.001
PLT (10^9·L^-1)	(75-322)	(84-404)	2.818	0.006
PLR	(38.78-234.17)	(62.22-288.24)	5.377	<0.001
RDW (%)	(11.60-14.50)	(11.4-19.0)	2.184	0.034
RBC (10^12·L^-1)	(3.01-5.25)	(3.20-5.68)	1.318	0.190
Hb (g·L^-1)	(98-159)	(96-168)	0.480	0.632
ALB(g·L^-1)	(25.0-47.1)	(28.6-46.0)	-0.123	0.902
GLU (mmol·L^-1)	(3.75-16.71)	(3.96-12.27)	0.368	0.713
TG (mmol·L^-1)	(0.41-2.99)	(0.46-7.92)	2.411	0.020
CHOL (mmol·L^-1)	(2.50-6.41)	(2.56-6.79)	0.919	0.360
HDL (mmol·L^-1)	(0.65-1.87)	(0.68-1.95)	-0.715	0.476
LDL (mmol·L^-1)	(0.93-4.29)	(1.14-4.60)	0.345	0.730
VLDL (mmol·L^-1)	(0.19-1.36)	(0.21-3.60)	2.412	0.020
ApoA1 (g·L^-1)	(0.65-1.67)	(0.65-1.70)	-0.525	0.601
ApoB (g·L^-1)	(0.33-1.29)	(0.40-1.41)	1.208	0.230
Lpa (mg·L^-1)	(8.2-679.2)	(2.10-932.22)	-0.205	0.838
hs-CRP (mg·L^-1)	(0.27-60.79)	(0.43-113.04)	2.250	0.029
D-D (mg·L^-1)	(0.01-8.97)	(0.01-9.86)	1.695	0.096
HCY (μmol·L^-1)	(6.44-14.92)	(15.09-109.94)	5.509	<0.001